CORSAIR CAPITAL MANAGEMENT, L.P. HBIO β€” HARVARD BIOSCIENCE INC

Ownership history in CORSAIR CAPITAL MANAGEMENT, L.P.  Β·  4 quarters on record

AI Ownership Summary

CORSAIR CAPITAL MANAGEMENT, L.P. reported HARVARD BIOSCIENCE INC (HBIO) in 4 quarterly 13F filings from 2024 Q3 through 2025 Q4. Peak portfolio weight reached 0.12% in 2025 Q4. The latest visible filing shows HBIO at 0.12% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this HBIO ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CORSAIR CAPITAL MANAGEMENT, L.P.'s position in HARVARD BIOSCIENCE INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

HBIO was reported at 0.12% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.12% in 2025 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

HBIO stock page CORSAIR CAPITAL MANAGEMENT, L.P. fund profile CORSAIR CAPITAL MANAGEMENT, L.P. full holdings
How CORSAIR CAPITAL MANAGEMENT, L.P. held HBIO β€” position size vs. price
% of Fund (quarterly)    HBIO price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED β€” β€” β€” 1,108,692 +1,008,692 +1008.7% 0.12% $741K 2026-02-17 $6.00
2025 Q3 ADDED β€” β€” β€” 100,000 +76,638 +328.0% 0.01% $44K 2025-11-14 $6.60
2024 Q3 REDUCED 64.9% -24.9% βœ… 23,362 -43,176 -64.9% 0.01% $63K 2024-11-13 $21.70
1 older quarter hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding HBIO

As of 2026 Q1 β€” sorted by position size

NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.53% Meros Investment Management, LP 3Y 0.25% TWO SIGMA ADVISERS, LP 3Y 7Y 0.0%

FAQ About CORSAIR CAPITAL MANAGEMENT, L.P. and HBIO

These are the practical questions this page is built to answer before you even open the full history table.

How long has CORSAIR CAPITAL MANAGEMENT, L.P. reported owning HBIO?

CORSAIR CAPITAL MANAGEMENT, L.P. reported HBIO across 3 quarterly 13F filings, from 2024 Q3 through 2025 Q4.

What was the largest reported HBIO position in CORSAIR CAPITAL MANAGEMENT, L.P.'s portfolio?

The largest reported portfolio weight for HBIO was 0.12% in 2025 Q4.

What is the latest reported HBIO position on this page?

The most recent filing on this page is 2025 Q4, when CORSAIR CAPITAL MANAGEMENT, L.P. reported 1,108,692 shares, equal to 0.12% of portfolio, with an estimated market value of $741K.

What does the chart on this HBIO ownership page compare?

The chart compares CORSAIR CAPITAL MANAGEMENT, L.P.'s quarterly HBIO portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did CORSAIR CAPITAL MANAGEMENT, L.P. time their HBIO position?

Based on 13F filing dates vs. subsequent HBIO price moves, CORSAIR CAPITAL MANAGEMENT, L.P. correctly timed 1 out of 3 reported position changes (33%).

← Back to CORSAIR CAPITAL MANAGEMENT, L.P. Holdings